rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

The company

STAAR Surgical Company

STAA · Nasdaq

Health CareMedical DevicesNot moving yet

STAA stood above a rising 150-day average in 22 of the last 52 weekly readings, and has been out of that trend for the last 9 weeks. It is 14.8% below that average now. Medical Devices: 27% of its 181 stocks in an uptrend (−9 points in four weeks); Health Care: 25% (−11 points in four weeks).

Statistics

Rotation
Not moving yet
Weeks in an uptrend
out for 9
Industry in uptrend
27% -9 in 4 wk
Insider buys, 12 months
$84.4M
Insider sales, 12 months
$0
Officials’ trades on record
1
Institutions holding
183 (+15)

In the rotation

Each square a week: lit when it closed above a rising 150-day average. 22 of 52 weeks.

17 Apr – 16 Oct
19%29%40%Apr 26Jun 26Jul 26Sep 26Oct 26

Medical Devices: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.

Money in and out

1 Nov 2024 – 1 Oct 2026
$0$39.6MNov 24May 25Nov 25Apr 26Oct 26

Open-market buys above the line and sales below, in dollars.

Congress and officials

1 disclosed lines: House 0, Senate 0, executive 1; 1 people.

WhoDidAmountTraded
Donald J. Trump Executive branch: Office of Government EthicsWhite House Officesold$1k–$15k29 Jul 2026filed 22 Sep 2026

Insiders

Buy orders, 12 months17
Sale orders, 12 months0
Buyers · sellers3 · 0
WhoDidSharesTraded
Broadwood Partners, L.p.Director, 10% ownerbought316,017at $18.6213 Mar 2026filed 13 Mar 2026
Broadwood Partners, L.p.Director, 10% ownerbought0at $0.0013 Mar 2026filed 13 Mar 2026
Broadwood Partners, L.p.Director, 10% ownerbought299,432at $18.1212 Mar 2026filed 13 Mar 2026
Broadwood Partners, L.p.Director, 10% ownerbought0at $0.0012 Mar 2026filed 13 Mar 2026
Broadwood Partners, L.p.Director, 10% ownerbought54,764at $17.5211 Mar 2026filed 13 Mar 2026
Broadwood Partners, L.p.Director, 10% ownerbought0at $0.0011 Mar 2026filed 13 Mar 2026
Broadwood Partners, L.p.10% ownerbought27,485at $22.059 Jan 2026filed 13 Jan 2026
Broadwood Partners, L.p.10% ownerbought0at $0.009 Jan 2026filed 13 Jan 2026
Broadwood Partners, L.p.10% ownerbought3,240at $21.948 Jan 2026filed 8 Jan 2026
Broadwood Partners, L.p.10% ownerbought0at $0.008 Jan 2026filed 8 Jan 2026
Broadwood Partners, L.p.10% ownerbought66,467at $22.007 Jan 2026filed 8 Jan 2026
Broadwood Partners, L.p.10% ownerbought0at $0.007 Jan 2026filed 8 Jan 2026

Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.

Institutions

Holders183+15 on the quarter
New · exited50 · 32
Reported value$1.6B

Quarter to 30 Jun 2026, against 31 Mar 2026; newest filing 31 Aug 2026.

ManagerSharesChange
BROADWOOD CAPITAL INCunchanged · filed 14 Aug 202616,123,842$462.6M00.0%
BlackRock, Inc.added · filed 7 Aug 20267,338,793$193.7M+118,627+1.6%
Madison Avenue Partners, LPadded · filed 14 Aug 20264,175,748$119.8M+1,734,070+71.0%
Yunqi Capital Ltdunchanged · filed 5 Aug 20263,257,130$93.4M00.0%
VANGUARD CAPITAL MANAGEMENT LLCreduced · filed 13 Aug 20263,252,058$46.0M-69,637−2.1%
Point72 Asset Management, L.P.added · filed 14 Aug 20262,437,446$69.9M+1,614,294+196.1%
GOLDMAN SACHS GROUP INCadded · filed 14 Aug 20262,160,857$61.7M+1,090,918+102.0%
VANGUARD PORTFOLIO MANAGEMENT LLCreduced · filed 13 Aug 20261,979,573$56.8M-144,016−6.8%
STATE STREET CORPreduced · filed 7 Aug 20261,902,687$50.9M-63,642−3.2%
GEODE CAPITAL MANAGEMENT, LLCreduced · filed 12 Aug 20261,663,145$31.4M-13,587−0.8%
31 Mar 2023 – 30 Jun 2026
155189223Mar 23Dec 23Dec 24Sep 25Jun 26

Everyone who traded it

Deborah J. Andrews Company insiderChief Financial Officer & EVP · last 14 Aug 20260 · 29
Magda Michna Company insiderChief Development Officer · last 14 Aug 20260 · 0
Warren Foust Company insiderPresident and CEO · last 14 Aug 20260 · 0
Donald J. Trump Executive branchWhite House Office · last 29 Jul 20260 · 1
Arthur C. Butcher Company insiderDirector · last 18 Jun 20261 · 0
Christopher Min Fang Wang Company insiderDirector · last 18 Jun 20260 · 0
Lilian Yansheng Zhou Company insiderDirector · last 18 Jun 20261 · 0
Lou Silverman Company insiderDirector · last 18 Jun 20261 · 2
Neal C. Bradsher Company insiderDirector, 10% owner · last 18 Jun 202670 · 6
Richard T. LeBuhn Company insiderDirector · last 18 Jun 20260 · 0
Wei Jiang Company insiderDirector · last 18 Jun 20260 · 0
Broadwood Capital Inc Company insider10% owner · last 13 Mar 202653 · 16

Same industry

RCEL Avita MedicalLeading+100%
ATRC AtriCureLeading+49%
HAE HaemoneticsLeading+48%
HTFL HeartflowLeading+40%

Distance from each stock’s own 150-day average.

Government contracts

No federal award is tied to it.

From its SEC filings

Profit per saleFY 2025 · to 2 Jan 202676.2%
Operating profit marginFY 2025 · to 2 Jan 2026-38.3%
Free cash flow marginFY 2025 · to 2 Jan 2026-16.7%
Return on capital employedFY 2025 · to 2 Jan 2026-23.9%
Research spendFY 2025 · to 2 Jan 202616.7%
Share count trendFY 2025 · to 27 Feb 20260.2%
Cash and equivalentsFY 2025 · to 2 Jan 2026$153.2M
Free cash flowFY 2025 · to 2 Jan 2026−$40.0M

Analyst forecasts

No analyst forecasts yet.